急性弹簧圈栓塞后血流导向装置治疗破裂脉络膜前动脉动脉瘤
单中心回顾性病例系列研究纳入2011年3月至2021年5月16例破裂脉络膜前动脉动脉瘤患者,急性期弹簧圈栓塞后择期行血流导向装置治疗,平均随访16.62±3.22个月,14/16例(87.5%)完全闭塞,无死亡或永久性病残,无再出血或再治疗。
要点
- 16例破裂脉络膜前动脉动脉瘤急性期栓塞后择期血流导向治疗,无再出血。
- 14/16例(87.5%)动脉瘤完全闭塞,2/16例(12.5%)近完全闭塞。
- 2例(12.5%)出现轻微缺血并发症(临床静默梗死),无死亡或永久性病残。
核心结论
- 急性弹簧圈栓塞后待蛛网膜下腔出血恢复再行血流导向装置分期治疗破裂脉络膜前动脉动脉瘤安全有效。
- 本系列中弹簧圈栓塞与血流导向装置治疗间期无再出血发生。
- 作者认为分期治疗应被视为挑战性破裂脉络膜前动脉动脉瘤患者的有效选择。
研究设计与样本
- 单中心回顾性病例系列研究,纳入2011年3月至2021年5月间接受急性期弹簧圈栓塞后择期血流导向装置治疗的破裂脉络膜前动脉动脉瘤患者。
- 排除直接弹簧圈栓塞或仅行血流导向装置治疗的患者。
- 共16例患者接受急性期弹簧圈栓塞以备后续血流导向装置治疗。
主要发现
- 所有患者均为蛛网膜下腔出血,于急性出血第0至3天接受急性期治疗。
- 平均最大动脉瘤直径5.44±3.39 mm,平均年龄54.12±12岁(范围32-73岁)。
- 两次治疗平均间隔24.06±11.83天。
- 2例(12.5%)术后出现轻微缺血并发症,磁共振血管造影显示为临床静默梗死;1例(6.2%)出现血流导向装置缩短的技术并发症, telescopically部署第二枚血流导向装置。
- 平均随访16.62±3.22个月,所有患者改良Rankin量表评分≤2;14/16例(87.5%)完全闭塞,2/16例(12.5%)近完全闭塞;无患者接受再治疗或发生再出血。
临床怎么用
- 作者认为,对于挑战性破裂脉络膜前动脉动脉瘤患者,急性弹簧圈栓塞后择期血流导向装置分期治疗应被视为有效选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Flow-diverter treatments are successful endovascular treatments in protecting important perforating branches during aneurysm treatments. Because these treatments are performed under antiplatelet therapy, acute flow-diverter treatments in ruptured aneurysms are still controversial. Acute coiling followed by flow diversion has emerged as an intriguing and feasible treatment option for ruptured anterior choroidal artery aneurysm treatment. As a single-center retrospective case series study, this study reported the clinical and angiographic results of staged endovascular treatment in patients with a ruptured anterior choroidal aneurysm. METHODS: This is a single-center retrospective case series study between March 2011 and May 2021. Patients with ruptured anterior choroidal aneurysm received flow-diverter therapy in a different session after acute coiling. Patients treated with primary coiling or only flow diversion were excluded. Preoperative demographic and presenting symptoms, aneurysm morphology, perioperative and postoperative complications, and long-term clinical and angiographic outcome as measured using the modified Rankin Scale and O'Kelly Morata Grading scale and also Raymond-Roy occlusion classification respectively. RESULTS: Sixteen patients underwent coiling in the acute phase to undergo flow diversion later. The mean maximum aneurysm diameter is 5.44 ± 3.39 mm. All patients had a subarachnoid hemorrhage and were treated acutely between days 0 and 3 of acute bleeding. The mean age at the presentation was 54.12 ± 12 years (32-73 years). Two patients (12.5%) had minor ischemic complications, which are seen on magnetic resonance angiography as clinically silent infarcts, after the procedure. One patient (6.2%) had a technical complication with the flow-diverter shortening and deployed a second flow diverter telescopically. No mortality or permanent morbidity was reported. The mean interval time between the 2 treatments was 24.06 ± 11.83 days. All patients were followed up with digital subtraction angiography; 14/16 patients (87.5%) had aneurysms that were completely occluded and 2/16 (12.5%) showed near-complete occlusion. Mean follow-up was 16.62 ± 3.22 months; all patients had modified Rankin Scale scores ≤2; 14/16 (87.5%) had a total occlusion 14/16 (87.5%) had near-complete occlusion. None of the patients had retreatment or rebleeding. CONCLUSIONS: Staged treatment of ruptured anterior choroidal artery aneurysms with acute coiling and flow-diverter treatment after recovery from subarachnoid hemorrhage is safe and effective. In this series, no cases of rebleeding occurred during the interval between coiling and flow diversion. Staged treatment should be considered a valid option in patients with challenging ruptured anterior choroidal aneurysms.
引用
- Senol YC, Sayin B, Oz ZG, et al. Treatment of Ruptured Anterior Choroidal Artery Aneurysms by Acute Coiling Followed by Flow Diversion. World Neurosurg. 2023. PMID: 37178914. doi:10.1016/j.wneu.2023.05.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。